Navigation Links
Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association
Date:8/20/2013

LOS ANGELES (Aug. 20, 2013) Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

This lifetime achievement award was established in 2003 and is the highest honor bestowed on researchers by the association. It is the third time Bernstein has been honored by the AHA. In 2005, Bernstein was a recipient of the Novartis Prize for Hypertension Research. Two years later, he was awarded the American Heart Association's Basic Research Prize.

Bernstein formally will receive the Distinguished Scientist title at the start of the American Heart Association Scientific Sessions, Nov. 16-20, in Dallas. He will join the ranks of 75 other eminent scientists, physicians and researchers including 11 Nobel Prize recipients and Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute whose significant scientific contributions have advanced the understanding and treatment of cardiovascular disease and stroke.

"Dr. Bernstein has earned the prestigious title of Distinguished Scientist by making several important discoveries concerning the role of angiotensin converting enzyme, often called ACE, in blood pressure control, renal function, immune response and reproduction," said Shlomo Melmed, MD, senior vice president of Academic Affairs, dean of the Cedars-Sinai medical faculty and the Helene A. and Philip E. Hixon Chair in Investigative Medicine. "His work in the laboratory fuels life-saving advances in patient care. This award is a testament to the outstanding creative scholarly achievements of Dr. Bernstein."

Bernstein has studied the human body's renin-angiotensin system since 1987. This collection of enzymes plays a critical role in the control of blood pressure and in kidney function. Bernstein is recognized internationally for his cloning of the angiotensin II receptor and for his many studies of angiotensin converting enzyme, the enzyme responsible for the production of the vasoconstrictor angiotensin II.


'/>"/>

Contact: Sally Stewart
sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Kenneth Kaushansky, M.D., and David J. Kuter, M.D., D.Phil., to present 2013 Ernest Beutler Lecture
2. Kenneth Davis, MD, President and CEO of The Mount Sinai Medical Center, to Speak on the Future of Medicine at the Aspen Ideas Festival in Colorado from June 26th to July 2nd, 2013
3. Westchester County Dentist Dr. Kenneth Magid, D.D.S. has been Selected for Fellowship in The International College of Dentists 2013
4. Nancy Andrews, M.D., Ph.D., and Elaine Jaffe, M.D., honored with 2013 Henry M. Stratton Medal
5. Katherine A. High, M.D., to present 2013 American Society of Hematology E. Donnall Thomas Lecture
6. BIDMCs George Tsokos, M.D., receives NIH MERIT award
7. Healdsburg District Hospital Welcomes Theresa L. Colosi, M.D., to their Orthopaedic and Total Joint Program
8. ASTRO Chairman Michael Steinberg, M.D., FASTRO, reaffirms Societys commitment to ending self-referral
9. Stephen K. Klasko, M.D., M.B.A., Named President of Thomas Jefferson University and President and CEO of TJUH System
10. Beaumont Cardiologist Kavitha Chinnaiyan, M.D., Receives Excellence in Research Award
11. Beaumont cardiologist Kavitha Chinnaiyan, M.D., receives excellence in research award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... planning services from offices headquartered in Jefferson County, is announcing the launch of ... in Birmingham. , The number of homeless women and children in Birmingham has ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Pharmacy, Inc. (NYSE: DPLO) has been recognized by the Detroit ... Standard. To learn more about Diplomat,s career opportunities, visit ... ... ... LLC, a research firm specializing in organizational health and workplace improvement. ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has ... and Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Electrodes Market is poised to grow at a CAGR of around ... the market is witnessing include advancements in extracellular microelectrode arrays and ...
Breaking Medicine Technology: